99 related articles for article (PubMed ID: 6138119)
1. Response of pulmonary circulation to oral pirbuterol in chronic airflow obstruction.
Peacock A; Busst C; Dawkins K; Denison DM
Br Med J (Clin Res Ed); 1983 Oct; 287(6400):1178-80. PubMed ID: 6138119
[TBL] [Abstract][Full Text] [Related]
2. Effects of pirbuterol and sodium nitroprusside on pulmonary haemodynamics in hypoxic cor pulmonale.
MacNee W; Wathen CG; Hannan WJ; Flenley DC; Muir AL
Br Med J (Clin Res Ed); 1983 Oct; 287(6400):1169-72. PubMed ID: 6138118
[TBL] [Abstract][Full Text] [Related]
3. The effect of six months of daily treatment with the beta-2 agonist oral pirbuterol on pulmonary hemodynamics in patients with chronic hypoxic cor pulmonale receiving long-term oxygen therapy.
Biernacki W; Prince K; Whyte K; MacNee W; Flenley DC
Am Rev Respir Dis; 1989 Feb; 139(2):492-7. PubMed ID: 2563321
[TBL] [Abstract][Full Text] [Related]
4. Early effects of intravenous terbutaline on cardiopulmonary function in chronic obstructive bronchitis and pulmonary hypertension.
Jones RM; Stockley RA; Bishop JM
Thorax; 1982 Oct; 37(10):746-50. PubMed ID: 7157213
[TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic heart failure with pirbuterol: acute haemodynamic responses.
Dawson JR; Canepa-Anson R; Kuan P; Whitaker NH; Carnie J; Warnes C; Reuben SR; Poole-Wilson PA; Sutton GC
Br Med J (Clin Res Ed); 1981 May; 282(6274):1423-6. PubMed ID: 6112039
[TBL] [Abstract][Full Text] [Related]
6. Pirbuterol: a new oral sympathomimetic amine for the treatment of congestive heart failure.
Sharma B; Hoback J; Francis GS; Hodges M; Asinger RW; Cohn JN; Taylor CR
Am Heart J; 1981 Sep; 102(3 Pt 2):533-41. PubMed ID: 6115572
[TBL] [Abstract][Full Text] [Related]
7. Acute and chronic effects of low dose almitrine bismesylate in the treatment of chronic bronchitis and emphysema.
Winkelmann BR; Leinberger H; Hertrich FF; Rapp W; Dieterich HA; Ansquer JC
Eur J Med; 1992 Dec; 1(8):469-81. PubMed ID: 1341206
[TBL] [Abstract][Full Text] [Related]
8. Nonbronchodilator effects of pirbuterol and ipratropium in chronic obstructive pulmonary disease.
Ashutosh K; Dev G; Steele D
Chest; 1995 Jan; 107(1):173-8. PubMed ID: 7813271
[TBL] [Abstract][Full Text] [Related]
9. Pirbuterol hydrochloride: evaluation of beta adrenergic agonist activity in reversible obstructive pulmonary disease and congestive heart failure.
Weber RW; Nelson HS
Pharmacotherapy; 1984; 4(1):1-10. PubMed ID: 6142449
[TBL] [Abstract][Full Text] [Related]
10. Effects of oral and inhaled salbutamol and oral pirbuterol on right and left ventricular function in chronic bronchitis.
Winter RJ; Langford JA; Rudd RM
Br Med J (Clin Res Ed); 1984 Mar; 288(6420):824-5. PubMed ID: 6142748
[TBL] [Abstract][Full Text] [Related]
11. A new beta-2 adrenoceptor agonist (pirbuterol) in the treatment of ischaemic heart failure.
Nelson GI; Silke B; Barker MC; Saxton CA; Taylor SH
Eur Heart J; 1982 Jun; 3(3):238-45. PubMed ID: 6125392
[No Abstract] [Full Text] [Related]
12. Transpulmonary angiotensin II formation and pulmonary haemodynamics in stable hypoxic lung disease: the effect of captopril.
Peacock AJ; Matthews A
Respir Med; 1992 Jan; 86(1):21-6. PubMed ID: 1565813
[TBL] [Abstract][Full Text] [Related]
13. The acute hemodynamic response to pirbuterol at rest and exercise in patients with heart failure with observations on long-term response.
Uretsky BF; Seecof RM; Reddy PS
Can J Cardiol; 1986; 2(2):80-5. PubMed ID: 3085906
[TBL] [Abstract][Full Text] [Related]
14. Symptoms, haemodynamics, and exercise capacity during long term treatment of chronic heart failure. Experience with pirbuterol.
Dawson JR; Canepa-Anson R; Kuan P; Reuben SR; Poole-Wilson PA; Sutton GC
Br Heart J; 1983 Sep; 50(3):282-9. PubMed ID: 6137226
[TBL] [Abstract][Full Text] [Related]
15. Improvement of gas exchange during inhibition of hypoxic pulmonary vasoconstriction by nitrendipine in piglets.
Escourrou PJ; Teisseire BP; Hérigault RA; Vallez MO; Dupeyrat AJ
Bull Eur Physiopathol Respir; 1986; 22(6):531-7. PubMed ID: 3828543
[TBL] [Abstract][Full Text] [Related]
16. Pirbuterol, an oral beta-adrenergic receptor agonist, in the treatment of chronic cardiac failure.
Weber KT; Andrews V; Janicki JS; Likoff M; Reichek N
Circulation; 1982 Dec; 66(6):1262-7. PubMed ID: 6128086
[TBL] [Abstract][Full Text] [Related]
17. Effect of intravenous terbutaline on arterial blood gas tensions, ventilation, and pulmonary circulation in patients with chronic bronchitis and cor pulmonale.
Stockley RA; Finnegan P; Bishop JM
Thorax; 1977 Oct; 32(5):601-5. PubMed ID: 594942
[TBL] [Abstract][Full Text] [Related]
18. Long term haemodynamic, pulmonary function and symptomatic effects of pirbuterol in COPD.
Neilly JB; Carter R; Tweddel A; Martin W; Hutton I; Banham SW; Stevenson RD
Respir Med; 1989 Jan; 83(1):59-65. PubMed ID: 2511610
[TBL] [Abstract][Full Text] [Related]
19. Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction without impairing gas exchange.
Pison U; López FA; Heidelmeyer CF; Rossaint R; Falke KJ
J Appl Physiol (1985); 1993 Mar; 74(3):1287-92. PubMed ID: 8482669
[TBL] [Abstract][Full Text] [Related]
20. Effects of fenoterol on oxygen transport in patients with chronic airflow obstruction.
Carlone S; Angelici E; Palange P; Serra P; Farber MO
Chest; 1988 Apr; 93(4):790-4. PubMed ID: 3349836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
